19
19
24
24
31
31
27
27
30
30
24
24
15
15
20
20
17
17
8
8
2020
2011
Company (261)University (11)Research Institution (5)
1 - 10 of 261
Sort by
SEC Filing
Accession Number0001193125-20-141636Form Type8-KAcceptance Date2020-05-13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 7, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification N…
SEC Filing
Accession Number0001193125-20-139026Form Type10-QAcceptance Date2020-05-11
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 CATALYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter…
SEC Filing
Accession Number0001193125-20-139277Form Type8-KAcceptance Date2020-05-11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): May 11, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification…
SEC Filing
Accession Number0001193125-20-126361Form Type10-KAcceptance Date2020-04-29
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A [Mark One] ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 CATALYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its char…
SEC Filing
Accession Number0001193125-20-100911Form Type8-KAcceptance Date2020-04-08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 8, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identificatio…
SEC Filing
Accession Number0001193125-20-075118Form Type8-KAcceptance Date2020-03-16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 16, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identificat…
SEC Filing
Accession Number0001193125-20-024885Form Type8-KAcceptance Date2020-02-05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): February 4, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identifica…
SEC Filing
Accession Number0001193125-20-001827Form Type8-KAcceptance Date2020-01-06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 6, 2020 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identificat…
SEC Filing
Accession Number0001193125-19-302591Form Type8-KAcceptance Date2019-11-27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENTREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 21, 2019 CATALYST PHARMACEUTICALS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 001-33057 76-0837053 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identific…
SEC Filing
Accession Number0001193125-19-290006Form Type10-QAcceptance Date2019-11-12
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 CATALYST PHARMACEUTICALS, INC. (Exact name of registrant as specified in its cha…
We found 261 documents that match your Search
Patents: 10
Clinical Trials: 5
SEC Filings: 246

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in